Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
The U.S. Food and Drug Administration said an advisory panel of experts would hold meetings this month to discuss authorizing booster doses of Moderna Inc and Johnson & Johnson's COVID-19 vaccines, and clearing Pfizer's vaccine for use in children.
The panel will discuss authorizing Pfizer Inc's COVID-19 vaccine for children aged five through 11 on Oct. 26, the FDA said on Friday.
Last month, the FDA authorized a booster dose of the Pfizer and BioNTech vaccine for older adults and some Americans at high-risk of illness.
Roughly 4 million Americans have received a booster dose as of Thursday, according to data from the Centers for Disease Control and Prevention.
The panel, called the Vaccines and Related Biological Products Advisory Committee, will hold a meeting on Oct. 14 to discuss a booster dose of the Moderna vaccine, and discuss J&J's boosters on Oct. 15.
The panel will also review data on receiving a booster dose of a different vaccine than the one used in the original vaccine series.
